About us

EVEXyS is a privately owned German-Finnish biotechnology company established in 2016 based on scientific breakthroughs in academic research on plasma extracellular vesicles (pEV) made by the founders of the company. These discoveries originate from systematic analyses of pEV from patients with different diseases, as well as basic research elucidating the biogenesis of extracellular vesicles.

EVEXyS has also developed innovative new technologies for facile and automatable isolation of pEV from human plasma in order to facilitate the adoption of pEV biomarker-based diagnostics into routine clinical use. EVEXyS is committed to being a leader in the upcoming pEV-driven revolution in medial diagnostics.